Switzerland - Export of Heparin for Therapeutic Use
Since 2014, Switzerland Export of Heparin for Therapeutic Use decreased by 17.8% year on year. At $12,350,596 in 2019, the country was ranked number 19 comparing other countries in Export of Heparin for Therapeutic Use. Switzerland is overtaken by Canada, which was number 18 with $14,797,149 and is followed by Australia at $6,702,333.73. China ranked the highest with $1,237,456,257.9 in 2019, a fall of 3% compared to 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro recorded the best 5 years average growth at +490.8% per year, while Greenland witnessed the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 12,350,596.00 |
| 2018 | 36,292,576.00 |
| 2017 | 38,020,788.00 |
| 2016 | 40,712,544.00 |
| 2015 | 34,002,092.00 |
Download all data from 1988 to 2019
How does Switzerland rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data | |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data | |
| 18 |
#18
Canada
|
14,797,149.00 | 2019 | -35.6 % | +2.6 % | View data | |
| 19 |
#19
Switzerland
|
12,350,596.00 | 2019 | -66.0 % | -17.8 % | View data | |
| 20 |
#20
Australia
|
6,702,333.73 | 2019 | -5.3 % | -0.2 % | View data | |